Design Therapeutics

DSGN

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-62.38M

EBITDA$-48.99M

EBIT$-49.59M

Pre-tax Income$-67.45M

Net Income$-49.59M

Cash Equivalent$32M

Total Debt$1.84M

Book Value$256.34M

Book Value Per Share4.53

Return on Equity (ROE)-20.66%

Return on Assets (ROA)-19.84%

Return on Invested Capital (ROI)-20.66%

Net Profit Margin-3600.00%

Current Ratio29.31

Quick Ratio29.16

Long-Term Debt / Equitynull